BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15546866)

  • 1. Alternative splicing microarrays reveal functional expression of neuron-specific regulators in Hodgkin lymphoma cells.
    Relógio A; Ben-Dov C; Baum M; Ruggiu M; Gemund C; Benes V; Darnell RB; Valcárcel J
    J Biol Chem; 2005 Feb; 280(6):4779-84. PubMed ID: 15546866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing of the p15 cdk inhibitor in glioblastoma multiforme.
    Simon M; Köster G; Ludwig M; Mahlberg R; Rho S; Watzka M; Schramm J
    Acta Neuropathol; 2001 Aug; 102(2):167-74. PubMed ID: 11563632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple effects on cell cycle control.
    Sánchez-Aguilera A; García JF; Sánchez-Beato M; Piris MA
    Oncogene; 2006 Apr; 25(18):2565-74. PubMed ID: 16331255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
    Stürzenhofecker B; Schlott T; Quentin T; Kube D; Jung W; Trümper L
    Leuk Lymphoma; 2003 Sep; 44(9):1587-96. PubMed ID: 14565663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's lymphoma cell lines express a fusion protein encoded by intergenically spliced mRNA for the multilectin receptor DEC-205 (CD205) and a novel C-type lectin receptor DCL-1.
    Kato M; Khan S; Gonzalez N; O'Neill BP; McDonald KJ; Cooper BJ; Angel NZ; Hart DN
    J Biol Chem; 2003 Sep; 278(36):34035-41. PubMed ID: 12824192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.
    Johnson JM; Castle J; Garrett-Engele P; Kan Z; Loerch PM; Armour CD; Santos R; Schadt EE; Stoughton R; Shoemaker DD
    Science; 2003 Dec; 302(5653):2141-4. PubMed ID: 14684825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors.
    Goodson ML; Jonas BA; Privalsky ML
    J Biol Chem; 2005 Mar; 280(9):7493-503. PubMed ID: 15632172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of alternatively spliced transcripts in leukemia cell lines by minisequencing on microarrays.
    Milani L; Fredriksson M; Syvänen AC
    Clin Chem; 2006 Feb; 52(2):202-11. PubMed ID: 16384885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel frameshift mutation in the p16/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16/INK4A/p14ARF locus.
    Lutful Kabir FM; Agarwal P; Deinnocentes P; Zaman J; Bird AC; Bird RC
    J Cell Biochem; 2013 Jan; 114(1):56-66. PubMed ID: 22833492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
    Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
    J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of GFRalpha1 receptor splicing variants with different biochemical properties is modulated during kidney development.
    Charlet-Berguerand N; Le Hir H; Incoronato M; di Porzio U; Yu Y; Jing S; de Franciscis V; Thermes C
    Cell Signal; 2004 Dec; 16(12):1425-34. PubMed ID: 15381258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
    Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
    Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of breast cancer cell lines by a low-density microarray.
    de Longueville F; Lacroix M; Barbuto AM; Bertholet V; Gallo D; Larsimont D; Marcq L; Zammatteo N; Boffe S; Leclercq G; Remacle J
    Int J Oncol; 2005 Oct; 27(4):881-92. PubMed ID: 16142302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
    Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
    Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.
    Yurchenko MY; Kashuba EV; Shlapatska LM; Sivkovich SA; Sidorenko SP
    Exp Oncol; 2005 Mar; 27(1):24-30. PubMed ID: 15812353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that "brain-specific" FOX-1, FOX-2, and nPTB alternatively spliced isoforms are produced in the lens.
    Bitel CL; Nathan R; Wong P; Kuppasani S; Matsushita M; Kanazawa H; Frederikse PH
    Curr Eye Res; 2011 Apr; 36(4):321-7. PubMed ID: 21714144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue.
    Yang T; Zhang JS; Massa SM; Han X; Longo FM
    Mol Carcinog; 1999 Jun; 25(2):139-49. PubMed ID: 10365916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells.
    Kennah E; Ringrose A; Zhou LL; Esmailzadeh S; Qian H; Su MW; Zhou Y; Jiang X
    Blood; 2009 May; 113(19):4646-55. PubMed ID: 19211505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
    Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
    Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.